228 related articles for article (PubMed ID: 12883465)
1. Role of acyclovir gel in herpes simplex: clinical implications.
Seth AK; Misra A; Umrigar D; Vora N
Med Sci Monit; 2003 Jul; 9(7):PI93-8. PubMed ID: 12883465
[TBL] [Abstract][Full Text] [Related]
2. Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications.
Seth AK; Misra A; Umrigar D
Pharm Dev Technol; 2004 Aug; 9(3):277-89. PubMed ID: 15458233
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
4. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of antiviral antibiotic 17997 on treatment of HSV-1 infected guinea pig skin infection.
Tao P; Wang S; Leng Q
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):125-7. PubMed ID: 11503040
[TBL] [Abstract][Full Text] [Related]
6. [Clinical comparison of two topical antiviral ointments in herpes].
Makleit L; Nagy M
Orv Hetil; 1995 Feb; 136(8):417-9. PubMed ID: 7885687
[TBL] [Abstract][Full Text] [Related]
7. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
[TBL] [Abstract][Full Text] [Related]
8. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice.
Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
10. Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH; Korting HC
Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
[TBL] [Abstract][Full Text] [Related]
11. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
12. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
13. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
14. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
15. Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity.
Bhat PV; Jakobiec FA; Kurbanyan K; Zhao T; Foster CS
Am J Ophthalmol; 2009 Nov; 148(5):779-789.e2. PubMed ID: 19674728
[TBL] [Abstract][Full Text] [Related]
16. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir suppression to prevent recurrent genital herpes at delivery.
Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
[TBL] [Abstract][Full Text] [Related]
18. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
19. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections.
Muţiu A; Sahnazarov N; Crişan I
Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Herpes simplex virus infections with topical antiviral agents.
Hamuy R; Berman B
Eur J Dermatol; 1998; 8(5):310-9. PubMed ID: 9683881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
